Effect of plasmid-mediated stable interferon-γ expression on proliferation and cell death in the SKOV-3 human ovarian cancer cell line

被引:5
|
作者
Lv, Huiming [1 ]
Zhang, Huiya [1 ]
Wu, Jiaolei [1 ]
Guan, Yongmei [1 ]
机构
[1] Harbin Med Coll, Affiliated Hosp 1, Reprod Unit, Harbin, Peoples R China
关键词
Interferon-gamma; immunotherapy; ovarian carcinoma vaccine; plasmid vector; proliferation; IFN-GAMMA; CARCINOMA-CELLS; 1ST-LINE TREATMENT; INDUCED APOPTOSIS; GENE-TRANSFER; IN-VITRO; THERAPY; GROWTH; CARBOPLATIN; ACTIVATION;
D O I
10.3109/08923973.2010.543685
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: High interferon-gamma (IFN-gamma) expression in tumors has been reported to be a favorable prognostic marker. Continuous exposure of ovarian cancer cells to IFN-gamma was previously shown to result in significant growth inhibition and apoptosis. Our goal in this study was to evaluate the effect of plasmid-mediated stable IFN-gamma expression on the SKOV-3 human ovarian carcinoma cell line. Methods: SKOV-3 cells were stably transfected with the pEGFP-IFN-gamma plasmid. IFN-gamma mRNA was detected by RT-PCR and IFN-gamma protein expression was measured by ELISA. Proliferation and cell death in transfected SKOV-3 cells were measured by methyl-thiazolyl tetrazolium (MTT) assay and Hoechst 33258 staining, respectively and compared with untransfected and empty vector-transfected cells. Results: pEGFP-IFN-gamma SKOV-3 cells efficiently expressed and secreted IFN-gamma. They exhibited significantly decreased cellular proliferation when compared with control untransfected or empty vector-transfected cells (P < 0.05). The mode of cell death was primarily apoptosis. Conclusions: Stable expression of IFN-gamma significantly inhibits the proliferation of ovarian carcinoma cells and has the potential to be used in clinical applications to treat ovarian carcinoma in the future.
引用
收藏
页码:498 / 503
页数:6
相关论文
共 50 条
  • [1] Effect of quercetin on the proliferation of the human ovarian cancer cell line SKOV-3 in vitro
    Ren, Ming-Xin
    Deng, Xiao-Hui
    Ai, Fang
    Yuan, Guo-Yan
    Song, Hai-Yan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (02) : 579 - 583
  • [2] Inhibitory Effects of Digoxin and Digitoxin on Cell Growth in Human Ovarian Cancer Cell Line SKOV-3
    Chou, Jou-Chun
    Li, Jie-Hau
    Chen, Chih-Chieh
    Chen, Chien-Wei
    Lin, Ho
    Wang, Paulus S.
    INTEGRATIVE CANCER THERAPIES, 2021, 20
  • [3] Localization and expression of osteopontin in a chitosan-treated ovarian cancer cell line, SKOV-3
    Regisford, E. Gloria C.
    Stone, Julia M.
    Carson, Laura E.
    Kelly-Brown, Cordella
    Traisawatwong, Pasakorn
    Hicks, Antoine
    CANCER RESEARCH, 2011, 71
  • [4] Expression of Kallikrein 6 in a Chitosan-Treated Ovarian Cancer Cell Line, SKOV-3
    Woodard, C.
    Williams, E.
    Otenyo, P.
    Peterson, D.
    Regisford, G.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [5] The Effects of Chitosan on Localization, Expression and Secretion of Osteopontin in an Ovarian Cancer Cell Line, SKOV-3
    Hicks, A. M.
    Stone, J.
    Taylor, T.
    Williams, E.
    Peterson, D.
    Carson, L.
    Regisford, G.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [6] Effect of Diallyl Trisulfide on Human Ovarian Cancer SKOV-3/DDP Cell Apoptosis
    Wan, Hui-Fang
    Yu, Le-Han
    Wu, Jin-Lan
    Tu, Shuo
    Zhu, Wie-Feng
    Zhang, Xia-Li
    Wan, Fu-Sheng
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (12) : 7197 - 7201
  • [7] Berberine enhances the sensitivity of radiotherapy in ovarian cancer cell line (SKOV-3)
    Aleissa, Mohammed S.
    AL-Zharani, Mohammed
    Alneghery, Lina M.
    Aleissa, Abdulmalik M.
    SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (01) : 110 - 118
  • [8] Knockdown of Nucleostemin in an ovarian cancer SKOV-3 cell line and its effects on cell malignancy
    Wang, Jiao
    Wang, Lu
    Ji, Qingchun
    Zhu, Hong
    Han, Shiyu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 487 (02) : 262 - 267
  • [10] The experimental study of bortezomib induce ovarian cancer SKOV-3,SKOV-3/DDP cell proliferation and drug resistance reversion.
    Liu, Z.
    Ma, N.
    Jiang, Z.
    Yang, G.
    Wang, J.
    Zhao, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)